跳至主要内容
临床试验/ACTRN12615000082505
ACTRN12615000082505已完成未知

A prospective study on the effects of risk-reducing bilateral salpingo-oophorectomy (RRBSO) in pre-menopausal women at risk of developing ovarian cancer on non-cancer outcomes including sexual function and menopause related quality of life.

Peter MacCallum Cancer Centre0 个研究点目标入组 224 人开始时间: 2015年2月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
224

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
Female

入选标准

  • Aged 18 - 50 years
  • Regular menstrual periods (if intact uterus)
  • No current vasomotor symptoms (hot flushes and night sweats)
  • Early follicular FSH of equal to or less than 15 UI/L
  • Estradiol > 100 pmol/L
  • At a high risk of developing breast and/or ovarian cancer
  • Planning to undergo RRBSO

排除标准

  • Previous bilateral salpingo-oophorectomy
  • Taking anti-estrogen agents or tamoxifen in the previous 3 months
  • Lactating or within 3 months of pregnancy
  • English non-speakers
  • Undiagnosed abnormal vaginal bleeding
  • Current pregnancy (to be excluded with pregnancy test where indicated)

研究者

发起方
Peter MacCallum Cancer Centre

相似试验

Impact of risk-reducing bilateral... | 临床试验